<DOC>
	<DOCNO>NCT01773122</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , pharmacokinetics ( PK ) dapsone subject acne vulgaris follow 28 day dose .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Dapsone Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>Diagnosis acne vulgaris Willing avoid excessive prolonged exposure ultraviolet light ( e.g. , sunlight , tan bed ) throughout study If male , subject must agree shave facial treatment area agree maintain routine shave regimen duration study willing avoid apply moisturizers , sunscreen , cosmetic ( except eye lip makeup ) , chemical peel throughout study Oral acne treatment within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>